Redsense Medical announces that newly appointed Pontus Nobréus will take over as CEO of the Company starting the 1st of August 2022. Outgoing CEO Patrik Byhmer, co-founder and large shareholder of Redsense, will transition into a new role as Chairman of the Board. The agreement was announced in May but an exact date when Nobréus would assume responsibilities and take over the helm at Redsense was still to be determined.

Nobréus combines a track record of driving sales through well-targeted commercialization with an unwavering commitment to innovation that truly benefits patients, and takes over the helm at Redsense to speed up its ongoing journey of growth.